.png){kind=logo}
Based on information received from the CGM every 5 minutes, the insulin pump makes automatic adjustments and corrections to your insulin delivery.
Life with type 2 diabetes just got easier
People who use insulin can experience automation with the MiniMedTM 780G system
Less stress around mealtimes with freedom from perfect carb counts.†
Meal DetectionTM technology‡
Automatically adjusts insulin when you under count carbs or forget to dose — these automatic adjustments help prevent post-meal highs.
Reduce the work of diabetes care
Skip daily injections with a pump featuring a 300 mL reservoir, for higher insulin needs, and a 7-day infusion set for fewer changes.
Wake up rested
Sleep better with a system that anticipates, adjusts, and corrects all day and night.§
Understanding how insulin pumps work
Explore how insulin pump therapy simplifies diabetes management by delivering precise, automated insulin adjustments to the body through a thin, flexible tube called an infusion set.
A complete system
MiniMedTM 780G insulin pump
MiniMedTM 780G insulin pump
Continuous glucose monitor (CGM)
Continuous glucose monitor (CGM)
Sensors measure and send sugar levels to the pump. We have all-in-one disposable CGM options. See options.
Infusion set
Infusion set
Allows for continuous and discreet delivery of insulin through a thin, flexible tube. Get up to 7 days of wear time with the Medtronic ExtendedTM infusion set.
Footnotes
† Refers to SmartGuard™ feature. Individual results may vary.
‡ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor
The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.
The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.
©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.